SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest driven by high short interest and rising borrow rates, fueling speculation about an impending short squeeze ahead of its upcoming earnings report. Investors are actively discussing the stock's potential for a significant breakout, emphasizing institutional acquisitions and the firm's role in the evolving enterprise AI market.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS Tech Inc. is generating significant community buzz due to its status as a low-float play and its history of volatile price swings following corporate actions like reverse splits. Traders are actively debating whether the stock represents a prime short-squeeze opportunity with potential for explosive gains or if it is a classic pump-and-dump scheme prone to rapid reversals and dilution risks.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investors react to a transformational 1.5 billion dollar acquisition of the Long Ridge Energy power plant, a strategic move aimed at pivoting the firm from a pure Bitcoin miner to a broader AI and HPC infrastructure provider. While the community is actively debating the company's management track record and the long-term impact of this capital-intensive expansion, the stock remains a focal point for high-beta traders monitoring the potential for a short squeeze alongside broader rotation into crypto-linked equities.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure as investors react to a lowered full-year bookings forecast, with the company attributing the slowdown to disruptive new age-verification and child safety measures. The community is sharply divided, with bulls viewing the dip as a long-term accumulation opportunity despite the near-term friction, while bears focus on the potential for continued user growth headwinds and regulatory risks.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is surging on the back of institutional interest and speculative enthusiasm surrounding its electro-optic polymer technology, which is increasingly viewed as a critical component for high-speed AI infrastructure. The community is buzzing over potential foundry partnerships and the broader validation of the sector, with many investors holding for long-term catalysts while closely monitoring for any official updates on commercialization.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors digest news of potential FDA leadership changes, with the community closely tracking rumors of a former company VP being considered for a key regulatory role. The optimism is fueled by strong HOPE-3 Phase 3 clinical data for its lead therapy, leading many to believe that the path to approval is nearing completion despite recent price volatility caused by speculative short-selling.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility and institutional attention as investors debate its role in the AI datacenter 'supercycle' versus concerns over its current valuation and lack of profitability. The community remains sharply divided, with bulls pointing to expanding production capacity and high-speed transceiver demand while shorts anticipate a potential correction due to the stock's rapid appreciation and insider activity.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is seeing a surge in investor optimism driven by positive registrations in key European markets and anticipation around upcoming AI and robotics product updates. The community remains deeply divided, with bulls actively buying calls to fuel a potential squeeze toward key technical levels while bears continue to highlight extreme valuation concerns and ongoing leadership volatility.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense scrutiny as shareholders debate the optics of a massive executive compensation package for CEO RJ Scaringe, even as the company works to ramp up R2 production. While the community remains divided over the firm's long-term path to profitability, investors are heavily focused on upcoming earnings and the potential for a significant shift in the stock's momentum.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending following the announcement of a massive $2.8 billion AI infrastructure expansion with Yotta Data Services, which has reignited intense community debate regarding the company's valuation, contract execution risk, and short-interest dynamics. While bullish investors point to the significant project pipeline and strategic partnerships as signs of a pending breakout, bears continue to express skepticism regarding the company's revenue recognition, lack of formal guidance, and history of unfulfilled promises.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vincerx Pharma ($VINC) shares were in the spotlight over the weekend following the company’s proposed merger with Oqory, a privately-held, clinical-stage company that develops ADCs for the treatment of multiple oncology conditions, with retail sentiment staying strong.Vincerx stock was up 64% in after-hours trading session on Friday.Upon completion of the proposed merger, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%.Vincerx plans to reduce its workforce and undertake cost-control measures, the company said. As part of this workforce reduction, its CEO Dr. Ahmed Hamdy has stepped down but will remain as chairman. Dr. Raquel Izumi has stepped down as president and COO and taken over as acting CEO in a consulting capacity; Alexander Seelenberger has stepped down as CFO.Retail sentiment on Stocktwits has remained ‘bullish’ on the stock. Message volumes are in the ‘normal’ zone.<figure class="image"><img style="aspect-ratio:1256/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_30_at_10_18_33_AM_bd88e280b0.png" alt="Screenshot 2024-12-30 at 10.18.33 AM.png" width="1256" height="302"><figcaption>VINC sentiment meter and message volumes on Dec 29 as of 11:45 pm ET</figcaption></figure><stembedurl>https://stocktwits.com/jlemx/message/598101092</stembedurl>The merger is subject to customary closing conditions and the completion of the minimum $20 million in financing, and the continued listing of Vincerx's common stock on Nasdaq.According to a Vincerx statement, the transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders.Additionally, certain Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches.The financing consists of about $1 million funded through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 funded on or prior to January 31, 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish

 Retail sentiment on Stocktwits has remained ‘bullish’ on the stock. 

Equity

Shares of Vincerx Pharma saw volatile trading on Wednesday, swinging between gains and losses after the company unveiled significant cost-cutting measures.&nbsp;The moves are aimed at advancing its VIP943 program, a cancer treatment for leukemias and myelodysplastic syndrome, the company said.Vincerx CEO Ahmed Hamdy reiterated the company’s commitment to VIP943, highlighting positive early results from the Phase 1 dose-escalation study.&nbsp;The trial showed promising safety and efficacy, with a relapsed AML patient achieving complete remission with incomplete blood count recovery (CRi) and a higher-risk MDS patient achieving complete remission with leukemic cells (CRL).&nbsp;Notably, the CRi patient showed significant improvement, with their bone marrow revealing only 1% cancer cells after seven months.To ensure the continued development of VIP943, Vincerx is taking aggressive steps to streamline operations and focus resources on the trial’s advancement.&nbsp;That includes a 55% reduction in force and exploring strategic alternatives such as out-licensing, mergers, or asset sales.&nbsp;The company also announced plans to engage a financial advisor to guide the strategic review process.<figure class="image"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/VINC_sentiment_and_message_volume_Dec_4_196f59dc07.png" alt="VINC sentiment and message volume Dec 4 .png" width="1318" height="318"><figcaption>VINC sentiment and message volume Dec 4 as of 10:45 am ET | source: Stocktwits</figcaption></figure>Retail activity surrounding VINC surged, with message volume on Stocktwits reaching the second-highest level in the past year, while sentiment remained ‘bullish’.&nbsp;One watcher speculated that a reverse stock split or partnership deal could be in the works.<stembedurl>https://stocktwits.com/HoHoHoHum/message/594996367</stembedurl><a href="https://stocktwits.com/symbol/VINC">Vincerx’s stock</a> has struggled, losing over 75% of its value year-to-date.&nbsp;As of Oct. 31, the company had $8.4 million in cash and is actively pursuing partnerships to advance other oncology treatments, including VIP236 for solid tumors and enitociclib for leukemia.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail activity surrounding VINC surged, with message volume on Stocktwits reaching the second-highest level in the past year.

Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials 

The company's plans include a 55% reduction in force and exploring strategic alternatives such as out-licensing, mergers, or asset sales.

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.

VINC
Vincerx Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results:

Historical Earnings

Latest VINC News

VINCVincerx Pharma Inc